BackBioventus Overview
Bioventus Inc - Ordinary Shares - Class A

Bioventus Target Price

Where could BVS trade next? Consensus target price: $18.

Get informed when a big investor buys or sells

+ Follow

Share Price

$11.42

Average Target Price

$18.3360.5% upside

3 analysts in the last 4 months

High: $19 | Low: $18

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-17Canaccord Genuity$1966.4% upsideOpen
2026-08-06Craig-Hallum$1857.6% upsideOpen
2026-08-06Barrington$1857.6% upsideOpen
2026-06-16Canaccord GenuityCaitlin Cronin$1531.3% upsideOpen
2026-02-09Barrington$1313.8% upsideOpen
2025-05-07Craig-HallumChase Knickerbocker$1531.3% upsideOpen
2024-10-01Canaccord GenuityCaitlin Cronin$125.1% upsideOpen
2024-08-07Craig-HallumChase Knickerbocker$125.1% upsideOpen
2024-05-07Canaccord GenuityWilliam Plovanic$829.9% downsideOpen
2024-03-13Craig-HallumAlex Nowak$921.2% downsideOpen
2022-11-30Goldman Sachs$2.578.1% downsideOpen

Bioventus (BVS) FAQ

Bioventus (BVS) currently reports a target price of $18. Use the charts on this page to explore Bioventus's target price history and peer comparisons.

Analysts' average 12-month price target for Bioventus is $18, about 60.5% upside from the current share price of $11.42. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $18, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Bioventus, and consider following BVS for alerts when major investors trade the stock.

Bioventus is classified in the Healthcare sector. On target price, it currently shows $18. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BVS with unrelated industries.